HC Deb 25 November 1997 vol 301 c516W
Ms Corston

To ask the Secretary of State for Health when he expects the Committee on Safety of Medicines to approve the recent recommendations of the Malaria Advisory Committee to restrict the use of Mefloquine (Lariam) by travellers. [15451]

Ms Jowell

The Committee on Safety of Medicines has no jurisdiction over the recommendations of the Malaria Advisory Committee but has reviewed these to determine whether they have any implications for the Marketing Authorisation and product information for Lariam.

In order to ensure that doctors are aware of the published guidelines, the product information advises doctors to refer to them.

Back to
Forward to